AI-Driven Precision Public Health & Biomarker Surveillance:

For more than a century, nutrition science operated on a comforting statistical fiction: the "average human." Open any standard clinical nutrition textbook or national policy manual, and you will find neat tables of Recommended Dietary Allowances, Estimated Average Requirements, and Glycaemic Index scores. If a hundred grams of boiled white rice carries a glycaemic index of 73, our charts assumed it raised blood glucose at roughly the same slope in a schoolteacher in Varanasi, a software engineer in Bengaluru, and a marathon runner in Nairobi. If an iron tablet failed to raise a pregnant woman’s haemoglobin at a rural sub-centre, we assumed she simply wasn't swallowing her pills.

Over the past decade, continuous biosensors, high-throughput metabolomics, gut microbiome sequencing, and machine-learning algorithms have dismantled that one-size-fits-all paradigm (1,2). We now know that two people sitting across the same dining table can eat the exact same katori of dal and chapati, yet experience completely opposite post-meal blood sugar spikes, triglyceride surges, and inflammatory responses (1,2).

Even more importantly, this scientific revolution is finally breaking out of wealthy Western academic laboratories and boutique wellness clinics. Today, the most urgent frontier in global health is Precision Public Health Nutrition: taking artificial intelligence, sub-phenotyping, and point-of-care biomarker surveillance out into the field to solve community-scale malnutrition and metabolic disease where the burden is highest (3,4).

The Death of the Universal Glycaemic Index

To understand why traditional dietary guidelines often miss the mark in individual clinics, we have to look at the landmark experiments that birthed modern precision nutrition. In 2015, Eran Segal, Eran Elinav, and David Zeevi at the Weizmann Institute of Science wired up a cohort of 800 individuals with continuous glucose monitors (CGMs) that recorded interstitial blood sugar every five minutes across an entire week, capturing responses to nearly 47,000 real-world meals (1). Alongside glucose curves, the researchers logged sleep patterns, physical activity, anthropometry,blood biochemistry, and 16S rRNA and shotgun metagenomic profiles of each participant's gut microbiome (1).

What they found stunned the nutrition world. When participants ate standardized, identical meals, their postprandial glycaemic responses varied wildly across individuals—even as each person’s response to the same food remained remarkably consistent from day to day (1). One participant experienced a steep, prediabetic glucose spike after eating a banana or tomatoes, yet maintained a flat glucose line after eating a cookie; another participant sitting next to them showed the exact opposite pattern (1). When the team fed clinical, anthropometric, and gut microbiota features into a stochastic gradient-boosting machine-learning algorithm, the model accurately predicted each person's unique glucose response to unrecorded meals—and short-term personalized dietary interventions designed by the algorithm successfully normalized postprandial dysglycaemia and reshaped the gut flora (1).

Five years later, Sarah Berry, Tim Spector, and colleagues expanded this inquiry in the PREDICT 1 clinical trial,studying over 1,000 adults—including hundreds of monozygotic and dizygotic twins—across the United Kingdom and the United States (2). Measuring post-meal blood glucose, insulin, and triglyceride trajectories for six hours after standardized metabolic challenge meals, they uncovered massive inter-individual variability: a 103% coefficient of variation for postprandial triglycerides, 68% for glucose, and 59% for insulin (2). Crucially, studying identical twins proved that host genetics explained less than half of a person's glucose response and less than 10% of their post-meal triglyceride clearance (2). Instead, modifiable factors—gut microbiome diversity, circadian meal timing, prior sleep architecture, meal composition, and previous-day physical activity—drove the way each body handled food (2).

Why South Asia Needs Precision Public Health More Than Anyone

When these precision nutrition studies first made headlines, public health researchers in low- and middle-income countries (LMICs) raised a valid critique. Continuous glucose sensors, shotgun metagenomics, and smartphone food-logging apps appeared to be expensive gadgets for the "worried well" in high-income countries. What relevance could precision nutrition possibly hold for a public health system wrestling with rural maternal anaemia, child stunting, and overburdened primary health centres?

As Shivani Misra and an international consortium of researchers argued in The Lancet Diabetes & Endocrinology, that scepticism gets the public health math backward (3). High-income Western nations built their medical guidelines around homogeneous European cohorts where obesity and type 2 diabetes largely follow a predictable trajectory of high BMI and hyperinsulinaemia. In contrast, populations across South Asia, sub-Saharan Africa, and Latin America exhibit far greater biological and environmental heterogeneity—meaning that blunt, Western-derived "one-size-fits-all" screening rules fail far more people in LMICs than anywhere else on Earth (3,5).

Look at how type 2 diabetes and cardiometabolic risk present across India. Using data-driven cluster analysis based on the paradigm pioneered by Emma Ahlqvist and colleagues, Viswanathan Mohan, Ranjit Mohan Anjana, and colleagues analysed nearly 19,000 Indian patients with newly diagnosed type 2 diabetes in the INSPIRED study (5). Unlike European populations where insulin resistance driven by frank obesity dominates, Indian patients clustered heavily into two distinct, high-risk metabolic phenotypes that strike decades earlier in life: Severe Insulin-Deficient Diabetes (SIDD)—characterized by young age at onset, relatively low BMI, poor pancreatic beta-cell reserve, and high risk of retinopathy—and a uniquely South Asian Combined Insulin-Resistant and Deficient Diabetes (CIRDD) phenotype marked by high visceral adiposity, severe insulin resistance, dyslipidaemia, and rapid progression to diabetic kidney disease (5).

Apply a standard Western public health screening rule—such as waiting until an adult crosses a BMI of 25 or 30 kg/m² to offer intensive dietary intervention—and you miss millions of young, normal-weight Indians whose pancreatic beta cells are already failing under the load of high-glycaemic cereal diets (3,5). Precision public health does not mean giving every villager a ten-thousand-rupee sensor; it means using simple, low-cost phenotypic markers—like waist-to-height ratios, age at onset, fasting triglycerides, and targeted anthropometry—to stratify communities into the right nutritional pathways before irreversible organ damage sets in (3,5).

Retiring the Clipboard: Point-of-Care Biomarker Surveillance

Nowhere is the transition from crude guesswork to precision public health more transformative than in how we measure micronutrient deficiencies in the field.

For decades, community nutrition surveys relied on two deeply flawed instruments: the 24-hour dietary recall clipboard and the single-drop finger-prick capillary haemoglobin test. Ask any field investigator who has conducted dietary recalls in rural households, and they will tell you how hard it is to translate shared family pots, seasonal variations, and social desirability bias into accurate milligram estimates of iron or zinc. Worse still, capillary blood squeezed from a finger-prick—often diluted by interstitial fluid when a health worker "milks" a cold finger—frequently misclassifies anaemia prevalence compared to venous blood auto-analysers (6).

Even when haemoglobin is measured accurately, haemoglobin alone is a blunt downstream number; it tells you a mother or child is anaemic, but it stays completely silent on why (7,8). As the Comprehensive National Nutrition Survey (CNNS) and recent global biomarker analyses led by Parminder Suchdev and the BRINDA (Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia) project have demonstrated, distributing blanket iron tablets based solely on low haemoglobin misses the biological mark in huge swathes of the population (7,8).

In settings where subclinical gut infections, impure water, and environmental enteropathy are widespread, the liver releases elevated levels of C-reactive protein (CRP) and alpha-1-acid glycoprotein (AGP), which in turn upregulate the hormone hepcidin (7). Elevated hepcidin slams shut the ferroportin gates on intestinal cells, blocking dietary iron absorption and trapping existing iron inside macrophages—a state where serum ferritin appears artificially normal or high even when the bone marrow is starving for iron (7). Conversely, in millions of other Indian children and pregnant women, anaemia is driven by severe vitamin B12 or folate depletion rather than iron scarcity (8).

Today, precision biomarker surveillance is replacing blind supplementation with multiplexed, field-ready diagnostics:

The Gut Microbiome as a Public Health Organ

Perhaps the most breathtaking application of precision nutrition in the Global South has happened not in wealthy weight-loss clinics, but in the rehabilitation of severely malnourished children.

For years, humanitarians were baffled by a tragic clinical paradox: even when children suffering from Severe Acute Malnutrition (SAM) or Moderate Acute Malnutrition (MAM) were given calorie-dense, vitamin-fortified Ready-to-Use Therapeutic Foods (RUTF), many failed to achieve catch-up linear growth, remained cognitively impaired, and relapsed soon after discharge.

Working closely with Tahmeed Ahmed and colleagues in Bangladesh, Jeffrey Gordon’s team at Washington University discovered the missing biological piece: malnourished children suffered from a stunted, immature gut microbiota that failed to develop alongside their chronological age (9). Even when flooded with conventional high-calorie therapeutic paste made of milk powder, peanut butter, oil, and sugar, their depleted microbial ecosystem could not harvest the nutrients or send the biochemical signals needed to stimulate bone growth, immune maturation, and neurodevelopment (9).

Using machine-learning models to map which bacterial taxa correlated with healthy infant growth and plasma growth-signalling proteins, the researchers screened local culturally acceptable ingredients—finally formulating Microbiota-Directed Complementary Food (MDCF-2) out of a precise blend of chickpea flour, soybean flour, peanut flour, and green banana pulp (9). In a landmark randomized controlled trial published in the New England Journal of Medicine,children with moderate acute malnutrition who received MDCF-2 achieved significantly faster rates of weight-for-length and weight-for-age recovery than children given a standard supplementary food containing more calories—alongside upregulated plasma proteins linked to bone ossification, central nervous system development, and reduced systemic inflammation (9). Precision nutrition proved that feeding the right microbial consortium with local whole foods beats dumping raw calories into a damaged gut.

Predictive Geospatial AI: Catching Hunger Before It Strikes

Zooming out to the district and state level, artificial intelligence is transforming public health nutrition from a reactive firefighting service into a predictive science (4,10). Historically, nutrition policymakers operated in the rearview mirror—waiting three to five years for massive household surveys like the NFHS to discover that stunting or anaemia had worsened in a particular district.

Today, geospatial machine-learning pipelines combine multi-spectral satellite imagery of vegetation health (Normalized Difference Vegetation Index), rainfall anomalies, local mandi food-price fluctuations, soil micronutrient and heavy-metal maps, and routine maternal-child health data from digital platforms (such as India's Poshan Tracker and HMIS) to forecast nutritional vulnerability months in advance (4,10). When a predictive model flags that rising pulse prices,unseasonal heat stress, and rising diarrhoeal cases in a specific cluster of blocks are about to trigger a surge in child wasting or maternal nutritional depletion, district health officers can pre-position targeted food baskets, ORS-zinc kits,and antenatal nutritional support before a single child slips below the severe wasting threshold (10).

Guardrails for the Algorithmic Plate

As exciting as these tools are, deploying AI and precision biomarkers in public health carries serious ethical and scientific responsibilities (3,4):

  1. Eliminating Algorithmic Bias Through Local Data: An AI dietary model trained on the gut microbiomes and eating habits of Boston or London residents will fail catastrophically if deployed in rural Uttar Pradesh or Tamil Nadu (3). India and other LMICs must build sovereign, open-access biobanks and metabolic phenotyping cohorts that reflect indigenous diets, regional cooking methods, genetic diversity, and local environmental exposures (3,5).
  2. Data Privacy and Digital Equity: Biometric and nutritional tracking systems must empower frontline ASHA and Anganwadi workers rather than turning them into data-entry clerks, while strictly safeguarding household health data against commercial exploitation by food and insurance corporations (4).
  3. Precision Must Complement, Never Replace, Upstream Structural Policy: No smartphone algorithm or continuous glucose sensor can compensate for polluted drinking water, unaffordable vegetables, or a school gate flooded with cheap ultra-processed junk food (3,4). Precision tools should sharpen the aim of public health interventions, never serve as an excuse to ignore poverty and broken food environments.

The Future is Both Personal and Public

The false divide between individualized clinical medicine and population-wide public health is fading fast. Whether we are formulating a chickpea-and-banana therapeutic food to repair a toddler’s gut microbiome, using a smartphone camera to screen an adolescent girl for anaemia without a needle, or stratifying young South Asian adults by their distinct metabolic phenotypes before diabetes takes hold, precision science is making public health smarter, fairer, and more humane. By retiring the myth of the "average human" and listening closely to the distinct biological signals of our communities, we can finally deliver the right nourishment, to the right person, at the exact moment their body needs it most.

References

  1. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079–94.
  2. Berry SE, Valdes AM, Drew DA, Asnicar F, Mazidi M, Wolf J, et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26(6):964–73.
  3. Misra S, Aguilar-Salinas CA, Chikowore T, Konradsen F, Ma RC, Motala AA, et al. The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries. Lancet Diabetes Endocrinol. 2023;11(11):836–47.
  4. Rodgers GP, Collins FS. Precision nutrition—the answer to what to eat to stay healthy. JAMA. 2020;324(8):735–6.
  5. Anjana RM, Baskar V, Nair ATN, Jebarani S, Siddiqui MK, Pradeepa R, et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis:the INSPIRED study. BMJ Open Diabetes Res Care. 2020;8(1):e001506.
  6. Neufeld LM, Larson LM, Kurpad A, Mburu S, Martorell R, Brown KH. Hemoglobin concentration and anemia diagnosis in venous and capillary blood: biological basis and policy implications. Ann N Y Acad Sci.2019;1450(1):172–89.
  7. Suchdev PS, Namaste SM, Aaron GJ, Raiten DJ, Brown KH, Flores-Ayala R, et al. Overview of the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) Project. Adv Nutr. 2016;7(2):349–56.
  8. Sarna A, Porwal A, Ramesh S, Agrawal PK, Acharya R, Johnston R, et al. Characterisation of the types of anaemia prevalent among children and adolescents aged 1–19 years in India: a population-based study. Lancet Child Adolesc Health. 2020;4(7):515–25.
  9. Chen RY, Mostafa I, Hibberd MC, Das S, Mahfuz M, Naila NN, et al. A microbiota-directed food intervention for undernourished children. N Engl J Med. 2021;384(16):1517–28.
  10. Osgood-Zimmerman A, Millear AI, Stubbs RW, Shields C, Pickering BV, Earl L, et al. Mapping child growth failure across low- and middle-income countries. Nature. 2018;555(7694):41–7.